Sherpa Healthcare Partners Launches Chinese Medical Tech Fund

ABOUT US

CX Tech is Caixin Global's real-time tech news portal, featuring 24-hour news, short-form analysis, and roundups from business and tech media in China.

TRENDING: Chinese Firms Urged to Fortify Online Brands as Cybersquatting Costs Mount

LATEST: Chinese Firms Urged to Fortify Online Brands as Cybersquatting Costs Mount; Tech Brief (Oct. 16): China’s Tech Minister Meets With Apple CEO; China Debuts Ultrafast Oscilloscope in Drive to Break Tech Barriers; Tech Brief (Oct. 15): Google to Invest $15 Billion in India for AI Hub; Tech Brief (Oct. 13): Wingtech Temporarily Loses Control of Dutch Chipmaker Nexperia; Tech Brief (Oct. 10): China’s AI Server Market Doubles; Tech Brief (Oct. 9): SoftBank to Acquire ABB’s Robotics Business; Tech Brief (Sept. 30): U.S. Widens Export Blacklist; U.S. Tightens Export Controls to Cover Subsidiaries of Blacklisted Firms; DeepSeek Unveils New Model With Sparse Attention, Slashes API Costs; Tech Brief (Sept. 29): Meituan’s Food-Delivery Platform Keeta Launches in Dubai; Chinese Chipmaker Moore Threads Gets Fast Track Approval to $1.1 Billion IPO; Chinese Drone Maker XAG Files for Hong Kong IPO After First Annual Profit; GPT Weekly: Nvidia to Invest $100 Billion in OpenAI; Tech Brief (Sept. 26): Trump Approves TikTok Deal; Xiaomi Ups the Stakes in Premium Market With iPhone-Style 17 Series; Yangtze Memory’s Parent Restructures to Pave Way for IPO Amid Sanctions Pressures; Tech Brief (Sept. 25): Alibaba Launches AI Models; Alibaba Bets Big on ‘AI + Cloud’ With New Models, Nvidia Deal; GlobalFoundries Boosts U.S. Investment, Adds China Fabs to Meet Auto Chip Demand

By Ding Yi / Jul 21, 2021 06:36 PM / Business & Tech

Guangdong-based venture capital firm Sherpa Healthcare Partners has closed its dollar-denominated Fund II focusing on early- to growth-stage investment in China’s medical industry, the company said on Tuesday, riding the wave of a financing frenzy among the country’s medical technology startups.

The fund will mainly provide financial support to China-based companies engaged in biotech research, biomedicine development, medical equipment manufacturing, medical diagnostics and medical services.

Sherpa did not disclose how much money it raised for the fund, but said that it was oversubscribed by investors including public pension funds, sovereign wealth funds, and asset management companies.

Last month, London-headquartered venture capital firm Eight Roads Ventures, an early investor in Alibaba, announced the launch of a $400 million fund to focus on early-stage investment in China-based medtech and life science companies.

Contact reporter Ding Yi (yiding@caixin.com) and editor Heather Mowbray (heathermowbray@caixin.com)

Share this article

Open WeChat and scan the QR code